QuidelOrtho Corp. Stock
QuidelOrtho Corp. Stock
QuidelOrtho Corp. shows a slight decrease today, losing -€0.140 (-0.970%) compared to yesterday.
The community is currently still undecided about QuidelOrtho Corp. with 0 Buy predictions and 2 Sell predictions.
A potential of -30.36%, resulting from comparing the current price of 14.36 € with the target price of 10 € for QuidelOrtho Corp., shows the chance of incurring significant losses.
Our community identified positive and negative aspects for QuidelOrtho Corp. stock for the coming years. 1 users see the criterium "Innovation" as a plus for the QuidelOrtho Corp. stock. On the other hand our users think that "General Risks" could be a problem in the future.
Pros and Cons of QuidelOrtho Corp. in the next few years
Pros
?
M***** P*******
?
S********** s********
?
B****
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of QuidelOrtho Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| QuidelOrtho Corp. | -0.970% | -1.441% | -6.327% | -32.897% | -42.560% | -81.818% | -87.958% |
| Agilent Technologies Inc. | -1.700% | -1.559% | 3.226% | 19.284% | 2.372% | 8.352% | -6.578% |
| Veeva Systems A | 1.200% | 7.840% | 13.812% | -29.073% | -7.702% | -4.820% | -36.988% |
| Boston Scientific | 1.250% | 4.084% | 8.487% | -55.957% | -50.221% | -14.080% | 5.384% |
Comments
QuidelOrtho (QDEL) had its price target raised by JPMorgan Chase & Co. from $11.00 to $12.00. They now have an "underweight" rating on the stock.
Show more
Ratings data for QDEL provided by MarketBeat
QuidelOrtho (NASDAQ:QDEL) had its price target lowered by analysts at JPMorgan Chase & Co. from $26.00 to $22.00. They now have an "underweight" rating on the stock.
Show more
Ratings data for QDEL provided by MarketBeat
QuidelOrtho Co. (NASDAQ: QDEL) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $44.00 price target on the stock.
Show more
Ratings data for QDEL provided by MarketBeat
News
Rice Hall James Buys QuidelOrtho Stock
On Feb. 13, 2026, Rice Hall James & Associates, LLC disclosed a buy of QuidelOrtho (NASDAQ:QDEL) in the fourth quarter.
An SEC filing dated Feb. 13, 2026, shows Rice Hall James & Associates, LLC
QuidelOrtho Corp Director Purchases 10k Shares as CFO Retires
Matthew Strobeck, a Board Director at QuidelOrtho Corp. (NASDAQ:QDEL), reported the purchase of 10,000 common shares on Feb. 13, 2026, for a total transaction value of ~$240,000, as disclosed in a